THBD and acute promyelocytic leukemia: There is no consensus on whether DIC associated with APL should be treated with heparin, thrombomodulin, or anti-fibrinolytic; however, different therapeutic regimens should consider their impact on the coagulation-anticoagulation balance in patients with APL [11].